輸入代號或公司名稱後按 Enter
4162

智擎

-0.20 (-0.36%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
54.60199成交張數14.81本益比1.60股價淨值比3.65%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入 · 未來期間為分析師共識預估(2026-09-09)

營業收入2025911年增 -63.9%
毛利率202594.3%最新一期
營業利益率202546.7%最新一期
每股盈餘20252.70年增 -77.9%
會計項目走勢20162017201820192020202120222023202420252026 預估 1 家2027 預估 1 家
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計0.2%0.3%4.4%10.1%3.5%5.7%7.6%6.3%1.9%5.7%
營業毛利(毛損)99.8%99.7%95.6%89.9%96.5%94.3%92.4%93.7%98.1%94.3%93.8%97.5%
營業毛利(毛損)淨額99.8%99.7%95.6%89.9%96.5%94.3%92.4%93.7%98.1%94.3%
推銷費用2.4%4.7%12.2%11.2%3.5%5.6%6.9%5.0%1.5%4.0%
管理費用9.0%8.9%26.4%26.7%7.2%12.5%14.5%12.1%4.7%10.7%
研究發展費用17.2%14.3%42.6%41.6%9.1%20.9%27.8%40.4%10.6%32.9%
預期信用減損損失(利益)-0.0%0.0%-0.0%0.0%0.0%
營業費用合計28.6%27.9%81.1%79.5%19.8%39.0%49.2%57.5%16.7%47.6%
營業利益(損失)71.2%71.8%14.5%10.4%76.7%55.4%43.2%36.1%81.4%46.7%50.4%81.8%
利息收入3.9%2.4%3.9%7.1%2.9%10.5%
其他收入2.7%5.4%22.4%22.4%0.8%27.8%4.6%0.4%0.0%0.0%
其他利益及損失淨額-0.0%-19.0%18.9%-16.9%-10.1%-2.3%8.3%0.4%1.5%-1.3%
財務成本淨額0.0%0.0%0.0%0.0%0.0%0.0%0.0%
營業外收入及支出合計2.6%-13.6%41.3%5.4%-5.4%27.9%16.8%7.9%4.4%9.2%
稅前淨利(淨損)73.8%58.2%55.8%15.8%71.3%83.3%60.0%44.0%85.7%55.9%
所得稅費用(利益)合計13.1%12.9%11.7%2.3%14.0%18.2%11.3%8.2%16.3%13.3%
繼續營業單位本期淨利(淨損)60.8%45.3%44.1%13.5%57.2%65.1%48.7%35.8%69.4%42.5%
本期淨利(淨損)60.8%45.3%44.1%13.5%57.2%65.1%48.7%35.8%69.4%42.5%
本期綜合損益總額60.7%45.4%44.1%13.5%57.4%64.9%48.7%35.8%69.4%42.5%
基本每股盈餘0.5%0.3%0.3%0.1%0.4%0.5%0.3%0.2%0.5%0.3%0.4%0.5%
繼續營業單位淨利(淨損)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
稀釋每股盈餘0.5%0.3%0.3%0.1%0.4%0.4%0.3%0.2%0.5%0.3%
國外營運機構財務報表換算之兌換差額-0.0%0.0%-0.0%-0.1%0.2%-0.2%0.0%
後續可能重分類至損益之項目:-0.1%0.2%-0.2%0.0%
其他綜合損益(淨額)-0.0%0.0%-0.0%-0.1%0.2%-0.2%0.0%
母公司業主(淨利∕損)60.8%45.3%44.1%13.5%57.2%65.1%48.7%53.8%68.9%
母公司業主(綜合損益)60.7%45.4%44.1%13.5%57.4%64.9%48.7%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。最右邊的預估欄是分析師共識預估(2026-09-09),營收、營業利益、母公司淨利、每股盈餘直接取共識平均,毛利由共識營收乘上共識毛利率推算,不是公司財測。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。